{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:23:52Z","timestamp":1767997432317,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":257,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.radonc.2012.09.008","type":"journal-article","created":{"date-parts":[[2012,10,12]],"date-time":"2012-10-12T17:54:03Z","timestamp":1350064443000},"page":"145-149","source":"Crossref","is-referenced-by-count":87,"title":["Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review"],"prefix":"10.1016","volume":"105","clinical-trial-number":[{"clinical-trial-number":"nct00573040","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Angela","family":"van Baardwijk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang A.","family":"Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"van Elmpt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren M.","family":"Bentzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Reymen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinus","family":"Wanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruud","family":"Houben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"\u00d6llers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Lambin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"De Ruysscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2012.09.008_b0005","doi-asserted-by":"crossref","first-page":"234S","DOI":"10.1378\/chest.07-1378","article-title":"Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition)","volume":"132","author":"Scott","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.radonc.2012.09.008_b0010","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/JTO.0b013e3181de7143","article-title":"Stereotactic radiotherapy for pulmonary oligometastases: a systematic review","volume":"5","author":"Siva","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2011.06.029","article-title":"Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery","volume":"101","author":"Palma","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.radonc.2011.04.005","article-title":"Withholding stereotactic radiotherapy in elderly patients with stage I non-small cell lung cancer and co-existing COPD is not justified: outcomes of a Markov model analysis","volume":"99","author":"Louie","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.radonc.2011.06.009","article-title":"Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure","volume":"101","author":"Andratschke","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2011.03.003","article-title":"Radiographic and metabolic response rates following image-guided stereotactic radiotherapy for lung tumors","volume":"99","author":"Mohammed","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0035","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.radonc.2012.09.008_b0040","first-page":"189","article-title":"Stereotactic ablative radiotherapy for stage I NSCLC: recent advances and controversies","volume":"3","author":"Senan","year":"2011","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.radonc.2012.09.008_b0045","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0050","first-page":"CD002935","article-title":"Radical radiotherapy for stage I\/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable)","author":"Rowell","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.radonc.2012.09.008_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-5002(03)00152-1","article-title":"The role of radiotherapy in treatment of stage I non-small cell lung cancer","volume":"41","author":"Qiao","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2012.09.008_b0060","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.2009.25.0753","article-title":"Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904","volume":"28","author":"Bogart","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0065","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1200\/JCO.2009.24.7221","article-title":"Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer","volume":"28","author":"van Baardwijk","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0169-5002(99)00019-7","article-title":"Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients","volume":"24","author":"Martel","year":"1999","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2012.09.008_b0075","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.ijrobp.2007.11.028","article-title":"Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial","volume":"71","author":"van Baardwijk","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.008_b0080","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijrobp.2007.09.048","article-title":"HI-CHART: a phase I\/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer","volume":"71","author":"De Ruysscher","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.008_b0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0167-8140(99)00087-0","article-title":"Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering Committee","volume":"52","author":"Saunders","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0090","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.radonc.2009.04.002","article-title":"A phase II trial of induction chemotherapy followed by continuous hyperfractionated accelerated radiotherapy in locally advanced non-small-cell lung cancer","volume":"93","author":"Jenkins","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0095","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ijrobp.2011.10.032","article-title":"Individualized dose prescription for hypofractionation in advanced non-small-cell lung cancer radiotherapy: an in silico trial","volume":"83","author":"Hoffmann","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.008_b0100","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijrobp.2007.10.053","article-title":"Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer","volume":"70","author":"Lagerwaard","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.008_b0105","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ijrobp.2010.04.056","article-title":"Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a phase II trial","volume":"80","author":"Bral","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.008_b0110","first-page":"221","article-title":"Initial clinical experience with stereotactic lung radiotherapy, based on a biological model-driven prescription method","volume":"1","author":"Hodge","year":"2011","journal-title":"J Radiosurg SBRT"},{"key":"10.1016\/j.radonc.2012.09.008_b0115","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1097\/JTO.0b013e31822e71d8","article-title":"Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer","volume":"6","author":"Haasbeek","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0120","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.radonc.2011.12.023","article-title":"Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors","volume":"102","author":"Nuyttens","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0125","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.ijrobp.2008.07.048","article-title":"Dose coverage beyond the gross tumor volume for various stereotactic body radiotherapy planning techniques reporting similar control rates for stage I non-small-cell lung cancer","volume":"72","author":"Arvidson","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.008_b0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2007.11.033","article-title":"Clinical implications of the implementation of advanced treatment planning algorithms for thoracic treatments","volume":"86","author":"Morgan","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0135","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ijrobp.2004.07.691","article-title":"A challenge to traditional radiation oncology","volume":"60","author":"Fowler","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.008_b0140","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semradonc.2008.04.005","article-title":"The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery","volume":"18","author":"Kirkpatrick","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0145","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1200\/JCO.2008.21.5681","article-title":"Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy","volume":"27","author":"Baumann","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0150","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/02841860600904862","article-title":"Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries","volume":"45","author":"Baumann","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0155","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.radonc.2008.07.013","article-title":"Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy","volume":"88","author":"Chen","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0160","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.radonc.2009.06.002","article-title":"Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer","volume":"93","author":"Kopek","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0165","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.radonc.2007.10.017","article-title":"A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer","volume":"85","author":"Koto","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0170","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.ijrobp.2009.12.022","article-title":"Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer","volume":"79","author":"Matsuo","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.008_b0175","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.ijrobp.2010.07.104","article-title":"A phase II trial of stereotactic body radiation therapy for operable T1N0M0 non-small cell lung cancer. Japan Clinical Oncology Group (JCOG0403)","volume":"78","author":"Nagata","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.008_b0180","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.ijrobp.2005.05.034","article-title":"Clinical outcomes of a phase I\/II study of 48Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame","volume":"63","author":"Nagata","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.008_b0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lungcan.2005.08.011","article-title":"Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer \u2013 mature results for medically inoperable patients","volume":"51","author":"Nyman","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2012.09.008_b0190","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/JTO.0b013e318074de34","article-title":"Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study","volume":"2","author":"Onishi","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0195","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lungcan.2009.05.007","article-title":"Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial","volume":"68","author":"Ricardi","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2012.09.008_b0200","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijrobp.2008.01.054","article-title":"Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers","volume":"72","author":"Salazar","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.008_b0205","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ijrobp.2008.04.043","article-title":"Stereotactic body radiotherapy for primary lung cancer at a dose of 50Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm","volume":"73","author":"Takeda","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.008_b0210","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijrobp.2009.05.004","article-title":"Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control","volume":"77","author":"Videtic","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.008_b0215","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/COC.0b013e3181ec63ae","article-title":"Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer","volume":"34","author":"Lanni","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0220","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/j.ijrobp.2011.03.052","article-title":"Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer","volume":"81","author":"Widder","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.008_b0225","unstructured":"ICRU. International Commission on Radiation Units and Measurements Report 50: prescribing, recording, and reporting photon beam therapy; 1993."},{"key":"10.1016\/j.radonc.2012.09.008_b0230","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.radonc.2009.03.006","article-title":"Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan","volume":"91","author":"Aerts","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2012.03.005","article-title":"The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer","volume":"104","author":"van Elmpt","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0240","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1200\/JCO.2010.30.3271","article-title":"European Organisation for Research and Treatment of cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer","volume":"28","author":"De Ruysscher","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2012.09.008_b0245","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.ijrobp.2009.06.091","article-title":"Radiation dose\u2013volume effects in the lung","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.008_b0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0958-3947(02)00088-2","article-title":"Influence of dose calculation model on treatment plan evaluation in conformal radiotherapy: a three-case study","volume":"27","author":"Miften","year":"2002","journal-title":"Med Dosim"},{"key":"10.1016\/j.radonc.2012.09.008_b0255","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0971-6203.48716","article-title":"Comparative study of convolution, superposition, and fast superposition algorithms in conventional radiotherapy, three-dimensional conformal radiotherapy, and intensity modulated radiotherapy techniques for various sites, done on CMS XIO planning system","volume":"34","author":"Muralidhar","year":"2009","journal-title":"J Med Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814012003830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814012003830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T06:28:58Z","timestamp":1542695338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814012003830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0167814012003830"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2012.09.008","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}